Loading...
Targeting RNA helicase DHX33 blocks Ras‐driven lung tumorigenesis in vivo
Ras has been found to be mutated in 30% of non‐small cell lung cancers, and its mutation has been regarded as a causal factor underlying tumorigenesis. However, no successful medicine has been developed so far to inhibit Ras for lung cancer treatment. We have previously identified DHX33 as a Ras dow...
Na minha lista:
| Udgivet i: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7540983/ https://ncbi.nlm.nih.gov/pubmed/32767810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14601 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|